The Most Trusted Name in Securities Class Action Law Firms

Over a billion dollars recovered for investors and counting

Camping World Holdings, Inc.

According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about

Read More

monday.com Ltd.

According to the lawsuit, defendants made false and/or misleading statements and/or concealed material adverse facts concerning the true state of monday.com’s revenue expansion outlook; notably

Read More

Aquestive Therapeutics, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose the true state of Aquestive’s New Drug Application (“NDA”) for Anaphylm;

Read More

Trip.com Group Limited

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: defendants recklessly understated the regulatory risk facing Trip.com as a

Read More

Nektar Therapeutics

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: enrollment in the REZOLVE-AA trial had not followed applicable instructions

Read More

America’s Car-Mart, Inc.

On September 4, 2025, during market hours, Benzinga published an article entitled “America’s Car-Mart Stock Plunges After Sales Volume Dip, Delinquency Uptick.” The article stated

Read More

Driven Brands Holdings Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose Driven Brands’ financial condition and the effectiveness of its internal controls

Read More

Orthofix Medical Inc.

Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Orthofix Medical Inc. (NASDAQ: OFIX).

Read More

Soleno Therapeutics, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: the Soleno Phase 3 clinical trial program for diazoxide choline

Read More

Eos Energy Enterprises, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Eos Energy was unable to achieve the ramp in production

Read More

Boston Scientific Corporation

According to the lawsuit, during the Class Period, defendants made positive statements to investors while, at the same time, disseminating materially false and misleading statements

Read More

Barclays PLC

On February 27, 2026, Reuters published an article entitled “Wall Street hit by UK mortgage lender collapse, raising fears of more credit ‘cockroaches.’” The article

Read More

Elauwit Connection, Inc.

On February 27, 2026, during market hours, Elauwit filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing non-reliance on “previously

Read More

Navan, Inc.

According to the lawsuit, the Offering Documents used to effectuate Navan’s IPO were false and misleading and omitted to state that, at the time of

Read More

Banco Santander, S.A.

On February 27, 2026, Reuters published an article entitled “Wall Street hit by UK mortgage lender collapse, raising fears of more credit ‘cockroaches.’” The article

Read More
Camping World Holdings, Inc.

According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about

Read More
monday.com Ltd.

According to the lawsuit, defendants made false and/or misleading statements and/or concealed material adverse facts concerning the true state of monday.com’s revenue expansion outlook; notably

Read More
Aquestive Therapeutics, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose the true state of Aquestive’s New Drug Application (“NDA”) for Anaphylm;

Read More
Trip.com Group Limited

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: defendants recklessly understated the regulatory risk facing Trip.com as a

Read More
Nektar Therapeutics

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: enrollment in the REZOLVE-AA trial had not followed applicable instructions

Read More
America’s Car-Mart, Inc.

On September 4, 2025, during market hours, Benzinga published an article entitled “America’s Car-Mart Stock Plunges After Sales Volume Dip, Delinquency Uptick.” The article stated

Read More
Driven Brands Holdings Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose Driven Brands’ financial condition and the effectiveness of its internal controls

Read More
Orthofix Medical Inc.

Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Orthofix Medical Inc. (NASDAQ: OFIX).

Read More
Soleno Therapeutics, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: the Soleno Phase 3 clinical trial program for diazoxide choline

Read More
Eos Energy Enterprises, Inc.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Eos Energy was unable to achieve the ramp in production

Read More
Boston Scientific Corporation

According to the lawsuit, during the Class Period, defendants made positive statements to investors while, at the same time, disseminating materially false and misleading statements

Read More
Barclays PLC

On February 27, 2026, Reuters published an article entitled “Wall Street hit by UK mortgage lender collapse, raising fears of more credit ‘cockroaches.’” The article

Read More
Elauwit Connection, Inc.

On February 27, 2026, during market hours, Elauwit filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing non-reliance on “previously

Read More
Navan, Inc.

According to the lawsuit, the Offering Documents used to effectuate Navan’s IPO were false and misleading and omitted to state that, at the time of

Read More
Banco Santander, S.A.

On February 27, 2026, Reuters published an article entitled “Wall Street hit by UK mortgage lender collapse, raising fears of more credit ‘cockroaches.’” The article

Read More

Our Mission

The Rosen Law Firm, P.A. is dedicated to recovering damages for shareholders victimized by corporate fraud and other misconduct. Our attorneys have a wealth of knowledge and experience handling complex financial litigation and winning significant victories and settlements for our clients. By focusing exclusively on securities class actions and derivative litigation, we have risen to the forefront of plaintiffs’ firms and have recovered damages totaling hundreds of millions of dollars for our clients. Our mission is to protect shareholders rights.

Featured News

Plaintiffs Reach Further Settlement in Just Energy Securities Class Action

TORONTO, Aug. 23, 2025 /CNW/ – The Court-appointed representatives of a class of former shareholders of Just Energy Group Inc. (“Just Energy”) have reached a settlement of the class action commenced following Just Energy’s August 2019 restatement of its financial statements. Just Energy’s insurers have agreed to pay US$25,000,000 to settle the claims made against Just Energy

Read More

FAQ

Class actions are lawsuits where one or more investors serve as the representative plaintiffs on behalf of a large group of investors that each purchased the same securities and suffered losses as a result of the same false statements or misconduct.  Class actions allow a court to decide the claims of many investors in a single lawsuit. This promotes efficiency, economy, and extends justice to investors whose claims are not large enough to merit an individual lawsuit.

This is the time period during which investors purchased securities in the company that is the subject of the class action.  Typically, the false statements or fraud begin on the first day of the class period and the full truth about the false statements or fraud is revealed on the last day of the class period.

A lead plaintiff is an investor that wishes to serve as a representative plaintiff in the class action on behalf of all the other investors that purchased securities during the Class Period.

The Lead Plaintiff’s role is to oversee the litigation with the assistance and advice of the class’s attorneys. Both the Lead Plaintiff and the class’s attorneys must direct the litigation for the benefit of the class foremost. Ultimately, it is the job of the Lead Plaintiff to decide what is a fair settlement amount for the Class and to approve any settlement offer.

Lead Counsel are the Class’s attorneys.  The Lead Plaintiff selects the Lead Counsel.  Lead Counsel should have extensive experience prosecuting securities class actions if they are to effectively represent investors in a securities class action. 

If the amount of your losses in the investment are significant to you, being a lead plaintiff allows you to be involved in the case and oversee important decisions in the litigation, particularly the amount of any settlement for investors.

Class action lawsuits often are filed when it would be impractical or prohibitively expensive for each person who was harmed to file an individual lawsuit, and they enable small shareholders or consumers to seek recovery from large corporations possessing much greater legal and financial resources. Generally, securities class actions are filed in the Federal District Courts and allege that the defendant(s) violated the Securities Act of 1933 and/or the anti-fraud provisions of the Securities Exchange Act of 1934. The typical class action takes at least 2-3 years to litigate, although the actual time it takes to resolve a case varies, depending on the complexity of the case, the issues involved, and other factors.

You can complete the online certification form on our website or at your request, we will email you a form to complete and you can send it back to us.

You do not pay any legal fees, costs or expenses. The Court will award the Lead Counsel any legal fees, costs or expenses from the money they recover for the class. If Lead Counsel doesn’t recover any money for the class, Lead Counsel doesn’t get paid any legal fees, costs or expenses.

Our Offices

image 62

New York

275 Madison Avenue,

40th Floor
New York, NY 10016
T: 212.686.1060
F: 212.202.3827

image 62 1

Los Angeles

355 South Grand Avenue, Suite 2450
Los Angeles, CA 90071
T: 213.785.2610
F: 213.226.4684

image 62 (2)

Philadelphia Metro

101 Greenwood Avenue,

Suite 520
Jenkintown, PA 19046
T: 215.600.2817

F: 212.202.3827

newark

New Jersey

One Gateway Center,

Suite 2600
Newark, NJ 07102
T: 973.313.1887
F: 973.833.0399

Get a Free Consultation

Email us at [email protected] 

The Rosen Law Firm is dedicated exclusively to recovering investment losses for investors in companies that have misrepresented material aspects of their business or whose officers and directors have breached their fiduciary duties to shareholders.  

Rosenlegal
Scroll to Top